Studing the Effect of Dexmedetomidin in Controlling Agitation in Patients With Bipolar Disorder(RCT)
- Conditions
- agitation.
- Registration Number
- IRCT20230630058623N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 104
All patients with bipolar disorder referred to Amirkabir Arak Hospital, who are in the treatment service of supervisors and consultants, and the treatment and medication regimen for their bipolar disorder is the same.
All bipolar patients who have signed an informed consent form to enter the study.
Patients in the age range of 18 to 45 years
Patients with BMI in the range of 20 to 30
Patients with bipolar disorder who do not have other psychiatric diseases at the same time.
No history of underlying heart, lung, kidney and liver diseases
No history of recent CVA or MI
Not receiving anticonvulsant drugs.
Absence of pregnancy and breastfeeding
Not allergic to dexmedetomidine
Patients who do not have very severe agitation
All patients who have severe agitation
All patients who have a severe allergy or reaction to the drug after injection and need cardiorespiratory support
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Agitation score. Timepoint: After drug injection in ECT recovery department. Method of measurement: Agitation scoring questionnaire.
- Secondary Outcome Measures
Name Time Method